Ophtesic (Anhydrous Lidocaine Hydrochloride)

Lidocaine, the active ingredient in Ophtesic, is a local anesthetic presented as a sterile injectable solution for ophthalmic use. It provides temporary numbing of the ocular surface for procedures and examinations. GNH USA supplies Ophtesic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, ophthalmology clinics and eye‑care centres worldwide.

GNH USA supplies Ophtesic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, ophthalmology clinics and eye‑care centres worldwide.

Ophtesic contains lidocaine, a sodium‑channel blocking agent used in ophthalmology to provide surface anesthesia.

- Corneal abrasion: facilitates painless examination and debridement. - Intra‑ocular surgery preparation: provides short‑term anesthesia for needle insertion and minor procedures. - Diagnostic eye tests: enables comfortable slit‑lamp and tonometry assessments. - Foreign body removal: numbs the ocular surface to allow safe extraction. - Post‑procedural discomfort relief: reduces pain after minor ocular interventions.

Adverse reactions to lidocaine ophthalmic solutions are generally mild and related to local irritation.

Common Side Effects: - Burning sensation - Stinging staphyl  - Red‑red  - Itching  - Tearing  - Mild conjunctival hyper‑hyper 

Serious or Rare Side Effects: - Corneal epithelial toxicity - Persistent corneal ulceration - Severe allergic  - Anaphylaxis  - Vision loss  - Endophthalmitis 

When ​​​  ​  ​   ​    …  

-   g  t \\  \\ \